Cargando…
Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation
BACKGROUND: Astaxanthin (AST) is a second-generation antioxidant with anti-inflammatory and neuroprotective properties and could be a promising candidate for Alzheimer’s disease (AD) therapy, but is shows poor oral bioavailability due to its high lipophilicity. PURPOSE: This study aimed to prepare a...
Autores principales: | Shehata, Mustafa K, Ismail, Assem A, Kamel, Maher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069509/ https://www.ncbi.nlm.nih.gov/pubmed/37020692 http://dx.doi.org/10.2147/IJN.S402447 |
Ejemplares similares
-
Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
por: Shehata, Mustafa K, et al.
Publicado: (2023) -
Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
por: Rodriguez-Ruiz, Violeta, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2022) -
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
por: Cunha, Sara, et al.
Publicado: (2021) -
Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin
por: Zhang, Kunchi, et al.
Publicado: (2013)